Higher clinical success in patients with ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus treated with linezolid compared with vancomycin: results from the IMPACT-HAP study

INTRODUCTION: Controversy exists regarding optimal treatment for ventilator-associated pneumonia (VAP) due to methicillin-resistant Staphylococcus aureus (MRSA). The primary objective of this study was to compare clinical success of linezolid versus vancomycin for the treatment of patients with MRSA...

Descripción completa

Detalles Bibliográficos
Autores principales: Peyrani, Paula, Wiemken, Timothy L, Kelley, Robert, Zervos, Marcus J, Kett, Daniel H, File Jr , Thomas M, Stein, Gary E, Ford, Kimbal D, Scerpella, Ernesto G, Welch, Verna, Ramirez, Julio A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095575/
https://www.ncbi.nlm.nih.gov/pubmed/24916853
http://dx.doi.org/10.1186/cc13914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095575/
https://www.ncbi.nlm.nih.gov/pubmed/24916853
http://dx.doi.org/10.1186/cc13914

Ejemplares similares